These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18211616)

  • 1. Pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers treated with trimethoprim-sulphamethoxazole.
    Shiveley L; Struthers-Semple C; Cox S; Sawyer J
    J Clin Pharm Ther; 2008 Feb; 33(1):45-54. PubMed ID: 18211616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and Lamivudine in the isolated perfused rat kidney.
    Nakatani-Freshwater T; Babayeva M; Dontabhaktuni A; Taft DR
    J Pharmacol Exp Ther; 2006 Nov; 319(2):941-7. PubMed ID: 16926264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Lamivudine on the plasma and intracellular pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers.
    Holdich T; Shiveley LA; Sawyer J
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2943-7. PubMed ID: 17242147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole.
    Moore KH; Yuen GJ; Raasch RH; Eron JJ; Martin D; Mydlow PK; Hussey EK
    Clin Pharmacol Ther; 1996 May; 59(5):550-8. PubMed ID: 8646826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of single oral doses of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor, in healthy volunteers.
    Holdich T; Shiveley L; Sawyer J
    Clin Drug Investig; 2006; 26(5):279-86. PubMed ID: 17163261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.
    Gaffney MM; Belliveau PP; Spooner LM
    Ann Pharmacother; 2009 Oct; 43(10):1676-83. PubMed ID: 19737995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro interactions between apricitabine and other deoxycytidine analogues.
    Bethell R; De Muys J; Lippens J; Richard A; Hamelin B; Ren C; Collins P
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2948-53. PubMed ID: 17517847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pharmacokinetics of apricitabine in the presence and absence of ritonavir-boosted tipranavir: a phase I, open-label, controlled, single-centre study.
    Cox S; Southby J; Linet O; Tackwell K; Borin M; Perry K
    Clin Drug Investig; 2009; 29(11):721-8. PubMed ID: 19813775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of food on the pharmacokinetics of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor.
    Holdich T; Sawyer J
    Expert Opin Pharmacother; 2008 Aug; 9(12):2021-5. PubMed ID: 18671458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-dose pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in patients with HIV-1 infection.
    Cahn P; Rolon M; Cassetti I; Shiveley L; Holdich T; Sawyer J
    Clin Drug Investig; 2008; 28(2):129-38. PubMed ID: 18211121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide.
    Chatton JY; Munafo A; Chave JP; Steinhäuslin F; Roch-Ramel F; Glauser MP; Biollaz J
    Br J Clin Pharmacol; 1992 Dec; 34(6):551-4. PubMed ID: 1493087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim-sulphamethoxazole does not affect the pharmacokinetics of sirolimus in renal transplant recipients.
    Böttiger Y; Brattström C; Bäckman L; Claesson K; Burke JT
    Br J Clin Pharmacol; 2005 Nov; 60(5):566-9. PubMed ID: 16236048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of apricitabine and other nucleoside reverse transcriptase inhibitors on replication of mitochondrial DNA in HepG2 cells.
    de Baar MP; de Rooij ER; Smolders KG; van Schijndel HB; Timmermans EC; Bethell R
    Antiviral Res; 2007 Oct; 76(1):68-74. PubMed ID: 17628710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic properties and tolerability of bevirimat and atazanavir in healthy volunteers: an open-label, parallel-group study.
    Martin DE; Galbraith H; Schettler J; Ellis C; Doto J
    Clin Ther; 2008 Oct; 30(10):1794-805. PubMed ID: 19014835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apricitabine: a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor for the treatment of nucleoside-resistant HIV infection.
    Wainberg MA; Cahn P; Bethell RC; Sawyer J; Cox S
    Antivir Chem Chemother; 2007; 18(2):61-70. PubMed ID: 17542150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antibiotic solutions (ciprofloxacin and trimethoprim + sulfamethoxazole) on rabbit tympanic membrane.
    Karasolihoglu A; Adali MK; Koten M; Seker V; Kutlu K
    Rev Laryngol Otol Rhinol (Bord); 1995; 116(2):153-6. PubMed ID: 7569380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No pharmacokinetic interaction between paliperidone extended-release tablets and trimethoprim in healthy subjects.
    Thyssen A; Cleton A; Talluri K; Leempoels J; Janssens L; Boom S; Eerdekens M
    Hum Psychopharmacol; 2009 Oct; 24(7):532-9. PubMed ID: 19693799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.
    Algorta J; Pena MA; Alvarez A; Maraschiello C; Maruhn D; Windisch M; Mucke HA
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim-sulphamethoxazole and metronidazole as prophylaxis in colorectal surgery: a study of bioavailability after an oral single dose.
    Raab Y; Rasmussen I; Odenholt I; Påhlman L
    Eur J Surg; 2001 Jan; 167(1):46-9. PubMed ID: 11213821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.